NO954094L - Fremgangsmåte og produkt for regulering av celle-responsivitet på eksterne signaler - Google Patents

Fremgangsmåte og produkt for regulering av celle-responsivitet på eksterne signaler

Info

Publication number
NO954094L
NO954094L NO954094A NO954094A NO954094L NO 954094 L NO954094 L NO 954094L NO 954094 A NO954094 A NO 954094A NO 954094 A NO954094 A NO 954094A NO 954094 L NO954094 L NO 954094L
Authority
NO
Norway
Prior art keywords
mekk
mek
amino acid
acid sequence
protein
Prior art date
Application number
NO954094A
Other languages
English (en)
Norwegian (no)
Other versions
NO954094D0 (no
Inventor
Gary L Johnson
Original Assignee
Nat Jewish Ct Immun & Respirat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Jewish Ct Immun & Respirat filed Critical Nat Jewish Ct Immun & Respirat
Publication of NO954094D0 publication Critical patent/NO954094D0/no
Publication of NO954094L publication Critical patent/NO954094L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coating With Molten Metal (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO954094A 1993-04-15 1995-10-13 Fremgangsmåte og produkt for regulering av celle-responsivitet på eksterne signaler NO954094L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/049,254 US5405941A (en) 1993-04-15 1993-04-15 MEKK protein, capable of phosphorylating MEK
PCT/US1994/004178 WO1994024159A1 (en) 1993-04-15 1994-04-15 Method and product for regulating cell responsiveness to external signals

Publications (2)

Publication Number Publication Date
NO954094D0 NO954094D0 (no) 1995-10-13
NO954094L true NO954094L (no) 1995-12-13

Family

ID=21958855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954094A NO954094L (no) 1993-04-15 1995-10-13 Fremgangsmåte og produkt for regulering av celle-responsivitet på eksterne signaler

Country Status (12)

Country Link
US (2) US5405941A (de)
EP (2) EP0694044B1 (de)
JP (1) JP4127850B2 (de)
KR (1) KR970702294A (de)
AT (1) ATE321129T1 (de)
CA (1) CA2160548A1 (de)
DE (1) DE69434670T2 (de)
FI (1) FI954894A0 (de)
NO (1) NO954094L (de)
NZ (1) NZ266067A (de)
PL (1) PL311142A1 (de)
WO (1) WO1994024159A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663314A (en) * 1992-11-20 1997-09-02 The Board Of Regents Of The University Of Washington Human signal transduction MAPK kinase
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay
US6074861A (en) * 1993-04-15 2000-06-13 National Jewish Center For Immunology And Respiratory Medicine MEKK proteins
US5981265A (en) * 1993-04-15 1999-11-09 National Jewish Center For Immunology And Respiratory Medicine Methods for regulating MEKK protein activity
US6333170B1 (en) * 1993-04-15 2001-12-25 National Jewish Center For Immunology And Respiratory Medicine Method and product for regulating cell responsiveness to external signals
US5597719A (en) * 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
US6037136A (en) * 1994-10-24 2000-03-14 Cold Spring Harbor Laboratory Interactions between RaF proto-oncogenes and CDC25 phosphatases, and uses related thereto
CA2172771A1 (en) * 1995-03-28 1996-09-29 Akiyoshi Tani Method for assaying map kinase
US5736381A (en) * 1995-05-19 1998-04-07 Davis; Roger J. Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US6136596A (en) 1995-05-19 2000-10-24 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5910417A (en) * 1996-05-31 1999-06-08 National Jewish Center For Immunology And Respiratory Medicine Regulation of cytokine production in a hematopoietic cell
WO1998018914A1 (en) * 1996-10-31 1998-05-07 Duke University Soluble tie2 receptor
US6300081B1 (en) 1996-11-15 2001-10-09 Cornell Research Foundation, Inc. Activated ras interaction assay
US20020055130A1 (en) * 1997-02-14 2002-05-09 National Jewish Center For Immunology And Respiratory Medicine Method and product for regulating apoptosis
US20050244846A1 (en) * 1997-02-14 2005-11-03 Johnson Gary L MEKK1 proteins and fragments thereof for use in regulating apoptosis
KR100426648B1 (ko) * 1997-03-26 2004-05-31 주식회사 엘지생명과학 고순도의활성화된미토겐활성단백질키네이즈키네이즈-1의제조방법
JP2002502394A (ja) * 1997-05-28 2002-01-22 メルコラ，ダニエル，エー． ストレス活性化プロテインキナーゼ（ｓａｐｋ）経路の阻害及び癌療法に対する細胞の増感
US6312934B1 (en) 1998-03-16 2001-11-06 National Jewish Center For Immunology And Respiratory Medicine Human MEKK proteins, corresponding nucleic acid molecules, and uses therefor
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
US6811992B1 (en) * 1998-05-14 2004-11-02 Ya Fang Liu Method for identifying MLK inhibitors for the treatment of neurological conditions
US6114517A (en) * 1998-12-10 2000-09-05 Isis Pharmaceuticals Inc. Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
US6168950B1 (en) 1999-07-23 2001-01-02 Isis Pharmaceuticals, Inc. Antisense modulation of MEKK1 expression
US6861239B1 (en) * 1999-09-20 2005-03-01 New York University Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
EP1085093A3 (de) * 1999-09-20 2002-10-30 New York University Gene und Polynukleotide assoziierte mit UV-induzierten Hautschäden und Verwendungen davon
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US6287860B1 (en) * 2000-01-20 2001-09-11 Isis Pharmaceuticals, Inc. Antisense inhibition of MEKK2 expression
DE10020138A1 (de) * 2000-04-14 2001-10-31 Ulf R Rapp Nukleinsäure codierend für zumindest eine raf Teilsequenz mit einer MEKK1 Bindungsstelle
AU8856201A (en) 2000-09-01 2002-03-13 Andel Inst Van Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
US6498035B1 (en) 2000-09-08 2002-12-24 Isis Pharmaceuticals, Inc. Antisense modulation of MEKK3 expression
AU2001296412A1 (en) * 2000-09-29 2002-04-08 Isis Pharmaceuticals, Inc. Antisense modulation of mekk4 expression
US20030212018A1 (en) * 2001-01-16 2003-11-13 Monia Brett P. Antisense modulation of mekk2 expression
US6806293B1 (en) * 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2002076496A1 (en) * 2001-03-22 2002-10-03 Van Andel Institute Anthrax lethal factor inhibits tumor growth and angiogenesis
WO2002098891A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
US20050227228A1 (en) 2001-06-05 2005-10-13 Lori Friedman Map3ks as modifiers of the p53 pathway and methods of use
US20040019918A1 (en) * 2002-06-05 2004-01-29 Atherogenics, Inc. Human MEKK2 protein and nucleic acid molecules and uses therefor
EP1514558A1 (de) * 2003-09-15 2005-03-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von MARKK oder MARKK-Antagonisten zur Behandlung von Pathologien die von einer erhöhten oder reduzierten Phosphorylierung des MARK- oder Tau-Proteins charakterisiert ist
JP4898710B2 (ja) 2005-02-11 2012-03-21 メモリアル スローン−ケタリング キャンサー センター 薬剤耐性ｅｇｆｒ突然変異体を検出するための方法および組成物

Also Published As

Publication number Publication date
FI954894L (fi) 1995-10-13
EP0694044A4 (de) 1998-02-04
DE69434670D1 (de) 2006-05-11
EP0755406B1 (de) 2006-03-08
CA2160548A1 (en) 1994-10-27
EP0694044B1 (de) 2006-03-22
FI954894A7 (fi) 1995-10-13
PL311142A1 (en) 1996-02-05
ATE321129T1 (de) 2006-04-15
AU697340B2 (en) 1998-10-01
WO1994024159A1 (en) 1994-10-27
EP0755406A4 (de) 1999-07-14
EP0694044A1 (de) 1996-01-31
JP4127850B2 (ja) 2008-07-30
NO954094D0 (no) 1995-10-13
AU6666394A (en) 1994-11-08
US5405941A (en) 1995-04-11
EP0755406A1 (de) 1997-01-29
KR970702294A (ko) 1997-05-13
DE69434670T2 (de) 2007-01-18
FI954894A0 (fi) 1995-10-13
JPH08509128A (ja) 1996-10-01
US5854043A (en) 1998-12-29
NZ266067A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
NO954094L (no) Fremgangsmåte og produkt for regulering av celle-responsivitet på eksterne signaler
Nelson The binding of detergents to proteins: I. The maximum amount of dodecyl sulfate bound to proteins and the resistance to binding of several proteins
Yoshizawa et al. Modulation of translation initiation in rat skeletal muscle and liver in response to food intake
Greene et al. Physical evidence for transferrins as single polypeptide chains
Nakai et al. Food proteins: properties and characterization
Reiss et al. Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions
Acton et al. Predominance of clathrin light chain LCb correlates with the presence of a regulated secretory pathway.
DE69112207D1 (en) "walk-through"-mutagenese.
Takeuchi et al. Mucosal gastrin receptor. III. Regulation by gastrin
Arnheim et al. Multiple genes for lysozyme in birds: studies on black swan egg white lysozymes
Tripp et al. Identification of phosphoproteins correlated with proliferation and cell cycle arrest in Saccharomyces cerevisiae: positive and negative regulation by cAMP-dependent protein kinase.
Lake Ribosome evolution: the structural bases of protein synthesis in archaebacteria, eubacteria, and eukaryotes
Durkin et al. Partial characterization of the mitogenic action of pp60v‐src, the oncogenic protein product of the src gene of avian sarcoma virus
Gronczewska et al. Bioenergetics of fish spermatozoa with focus on some herring (Clupea harengus) enzymes
Mulgaonkar et al. Alterations in Rat Serum Proteins in Folic Acid and Vit. B12 Deficiency.
Lehmann et al. Biosynthesis of bacterial glycogen: purification and properties of Salmonella typhimurium LT-2 adenosine diphosphate glucose pyrophosphorylase
Urushizaki et al. Phosphorylation of hydroxylysine residues in collagen synthesized by cultured aortic smooth muscle cells.
Allison et al. Penguin blood serum proteins
ROSEMAN A bacterial phosphotransferase system and its role in sugar transport
TAMURA et al. Mechanism of temperature-induced synchrony in Tetrahymena pyriformis. Analysis of the leading cause of synchronization
Godovac-Zimmermann Isolation, characterization and N-terminal amino-acid sequence of rabbit transferrin
Vol'kenshteĭn Biopolymers and evolution
Marx Taking a Direct Path to the Genes: New work suggests that the path by which interferon signals are transmitted from the membrane to the genes in the nucleus is very direct. Could the same be true for other regulatory molecules?
Potter Hormonal induction of enzyme functions, cyclic AMP levels and AIB transport in Morris hepatomas and in normal liver systems
Bressani Laboratory evaluation of protein-rich mixtures